Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID causes lasting symptoms in many body systems, needing more research for better treatments.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The patient with lupus and hair loss improved with oral and topical minoxidil.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

The document updated knowledge on skin disorders, focusing on unusual moles in older adults, the progression from moles to melanoma, and evolving hair loss treatments.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Baricitinib successfully treated severe hair loss.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

Upadacitinib effectively treats psoriasis and lichen planus together.

Rats had lasting erectile problems after stopping a certain medication.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Omeprazole effectively treats severe acid reflux in children for short-term use, but long-term safety needs more research.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

Finasteride for hair loss has minimal impact on sexual function.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.